Similar articles

• Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.

  Marcus SC, Durkin M. Marcus SC, et al. J Am Acad Child Adolesc Psychiatry. 2011 May;50(5):480-9. doi: 10.1016/j.jaac.2011.02.007. Epub 2011 Apr 7. J Am Acad Child Adolesc Psychiatry. 2011. PMID: 21515197
• Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.

  Pae CU. Pae CU. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1149-50; author reply 1151-2. doi: 10.1016/j.pnpbp.2007.03.018. Epub 2007 Apr 1. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17493730 No abstract available.
• OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.

  Marchant BK, Reimherr FW, Halls C, Williams ED, Strong RE. Marchant BK, et al. Ann Clin Psychiatry. 2010 Aug;22(3):196-204. Ann Clin Psychiatry. 2010. PMID: 20680193 Clinical Trial.
• [Attention deficit hyperactivity disorder in children].

  Bervoets L. Bervoets L. J Pharm Belg. 2002 Mar-Apr;57(2):25-32. J Pharm Belg. 2002. PMID: 12053824 Review. French. No abstract available.
• Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.

  Gruber R. Gruber R. Child Adolesc Psychiatr Clin N Am. 2009 Oct;18(4):863-76. doi: 10.1016/j.chc.2009.04.011. Child Adolesc Psychiatr Clin N Am. 2009. PMID: 19836693 Review.